Live: Snowflake Break After Q1 Earnings Tonight
Snowflake is set to report Q1 FY2027 after the market closes, testing whether AI-driven demand translates into real p...
Fundamental analysis is key to maximizing stock returns. By evaluating financial health, you can make informed investment choices that lead to higher profits.
22,179 articlesSnowflake is set to report Q1 FY2027 after the market closes, testing whether AI-driven demand translates into real p...
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
A private investment strategy disclosed a $100 million Bitcoin buy funded by a stock sale, boosting its BTC reserves ...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
CoreWeave rode the AI compute wave, but headwinds have grown. This guide explains what's wrong with CoreWeave, the co...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A seemingly casual moment between two public figures sparked a wave of chatter online. In this article, we unpack why...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A Bernstein Research note argues Bitcoin has likely formed a cycle bottom and pins a $450 target on Strategy stock, s...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
Snowflake posted a record quarter, but its stock trades far from its peak as investors weigh whether AI-driven growth...